Pivotal-Point Tracking Disc Medicine (IRON): FDA Priority Voucher Accelerates Bitopertin!

Disc Medicine is a clinical biotechnology company focused on the discovery, development, and commercialization of novel treatments for severe hematological diseases (blood disorders). The company is developing innovative, potentially "First-in-Class" therapies that target fundamental biological pathways of heme synthesis and iron metabolism. The lead product is Bitopertin, which is being developed for the treatment of Erythropoietic Protoporphyria (EPP) - a rare genetic disorder that causes extreme sensitivity to light in patients. On October 17,...